15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering STERIS plc, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $269.00 to $275.00, so the covering firms are broadly aligned. The average target of $271.33 sits 21% above the current $224.51. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.81 next quarter toward $12.25 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Strong Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to STERIS plc.
As of Sep, 3 of 3 firms rate STE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
STE EPS & revenue forecast
EPS · NEXT QUARTER
$2.81
Range $2.77 – $2.83 · 8 analysts · +11% YoY
Next period, 8 analysts expect STERIS plc to earn $2.81 a share (range $2.77 – $2.83), versus $2.53 a year earlier. Full-year consensus is $11.17, growing to $12.25 the year after.
REVENUE · NEXT QUARTER
$1.6B
Range $1.6B – $1.6B · 8 analysts · +8% YoY
Revenue is expected to reach $1.6B (range $1.6B – $1.6B), +7.6% year-over-year. Full-year consensus is $6.4B, rising to $6.8B next year.
Top analysts covering STERIS plc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on STE.
#1
Mike Matson
Needham · Rank #210
Hold
No targeton STE
Overall win rate
34%
+ Follow
#2
Jason Bednar
Piper Sandler · Rank #276
Buy
$275.00+22.5% to target
Overall win rate
35%
+ Follow
#3
David Turkaly
JMP Securities · Rank #346
Buy
$280.00+24.7% to target
Overall win rate
33%
+ Follow
#4
Reni J. Benjamin
JMP Securities · Rank #366
Buy
$265.00+18.0% to target
Overall win rate
32%
+ Follow
#5
PW
Patrick Wood
Morgan Stanley
Buy
$295.00+31.4% to target
Coverage
—
+ Follow
STE stock forecast FAQ
What is STE's average 12-month price target?+
The 3 analysts with a live target average $271.33 for STERIS plc over the next 12 months, ranging from a $275.00 high to a $269.00 low.
Is STE stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for STE?+
The Street-high target is $275.00 (Piper Sandler), and the Street-low is $269.00 (Keybanc). The average of all 3 active targets is $271.33.
How many Wall Street analysts cover STE?+
3 analysts have an active rating on STERIS plc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering STE?+
Among analysts who currently cover STE, Mike Matson of Needham has the strongest overall Quantellect track record (Rank #210). Their current call is Hold.
What is STERIS plc's projected EPS for next quarter?+
The consensus estimate is $2.81 per share (range $2.77 – $2.83) across 8 analysts. Full-year EPS is projected at $11.17, rising to $12.25 the following year.
How much revenue is STERIS plc expected to report next quarter?+
Consensus revenue is $1.6B (range $1.6B – $1.6B). Full-year revenue is projected at $6.4B, growing to $6.8B next year.
Have analysts been upgrading or downgrading STE lately?+
As of Sep, 3 of 3 firms rate STE a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their STE calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
UBS
